|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Endothelium specific loss of murine t hrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile - onset thrombosis 显示文摘 | ISERMANN B HENDRICKSON S B ZOGG M | 2001 | Clin Invest2001，108，： | 1 |
| 2 | Endotheliumspecific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenileonset thrombosis显示文摘 | Isermann B Hendrickson SB Zogg M | 2001 | Clin Invest2001，108，4： | 1 |
| 3 | Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis 显示文摘 | Isermann B Hendrickson SB Zogg M | 2001 | J Clin Invest2001，108，4： | 1 |
| 4 | Ovarian cancer BRCA1 mutation detection: protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP)显示文摘 | Geisler J P Hatterman Zogg M A Rathe J A | 2001 | Human mutation2001，18，4： | 1 |
| 5 | Electrosprayed and selenized Cu/In metal particle films显示文摘 | Kaelin M Zogg H Tiwari A N | 2004 | Thin Solid Films2004，457，2： | 1 |
| 6 | Endothelium- specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis 显示文摘 | Isermann B Hendrickson SB Zogg M | 2001 | J Clin Invest2001，108，： | 1 |
| 7 | Endothlium - specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and cause juvenile - onset thrombosis 显示文摘 | Isemann B Hendrickson S B Zogg M | 2013 | J Clin Invst2013，108，4： | 1 |
| 8 | Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis 显示文摘 | ISERMANN B HENDRICKSON S B ZOGG M | 2001 | Clin Invest2001，108，4： | 1 |
| 9 | Endotheliumspecific loss of murine thrombomodulin disrupts the protein C antiooagulant phatway and causes juvenlie-onset thrombosis显示文摘 | HENDRICKSON SB ZOGG M | 2001 | J Clin Invest2001，108，： | 1 |
| 10 | Activated protein C targets CD8 + dendritic cells to reduce the mortality of endotoxemia in mice显示文摘 | Kerschen E Hernandez I Zogg M | 2010 | J Clin Invest2010，120，9： | 1 |
| 11 | CIS and CIGS layers from selenized nanoparticle precursors显示文摘 | M Kaelin D Rudmann F Kurdesau T Meyer H Zogg A N Tiwari | 2003 | Thin Solid Films2003，431，： | 1 |
| 12 | Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis 显示文摘 | Isermann B Hendrickson SB Zogg M | 2001 | J Clin Invest2001，108，4： | 1 |
| 13 | Electrosprayed and selenized Cu/In metal particle films 显示文摘 | Kaelin M Zogg H Tiwari A N | 2004 | Thin Solid Films2004，457，2： | 1 |
| 14 | Larmdesign moderner Triebfahrzeuge am Beispiel der Lok 2000 Familie, Anwendung von Telemetrie, Intensitats-und Arraymesstechnik显示文摘 | Zogg H | 1995 | ZEV+DET Glasers Annalen1995，119，910： | 1 |
| 15 | Mass transfer in Sulzer mesh packing 显示文摘 | Zogg M | 1973 | Chemic Ingenieur Technik1973，45，2： | 1 |
| 16 | Surgical outcomes of pulmonary resection for lung cancer after neo-adjuvant treatment显示文摘AIM: To evaluate the outcomes of surgery for lung cancer after induction therapy.METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program(ACSNSQIP) database(2005-2012), we identified 4063 patients who underwent a pulmonary resection for lung cancer. Two hundred and thirty-six(5.8%) received neo-adjuvant therapy prior to surgery(64 chemo-radiation, 103 radiation alone, 69 chemotherapy alone). The outcomes were compared to 3827 patients(94.2%) treated with surgery alone. Primary outcome was 30-d mortality, and secondary outcomes included length of stay, operative time and NSQIP measured postoperative complications.RESULTS: Lung cancer patients who received preoperative treatment were younger(66 vs 69, P < 0.001), were more likely to have experienced recent weight loss(6.8% vs 3.5%; P = 0.011), to be active smokers(48.3 vs 34.9, P < 0.001), and had lower preoperative hematological cell counts(abnormal white blood cell: 25.6 vs 13.4; P < 0.001; low hematocrit 53% vs 17.3%, P < 0.001). On unadjusted analysis, neo-adjuvant patients had significantly higher 30-d mortality, overall and serious morbidity(all P < 0.001). Adjusted analysis showed similar findings, while matched cohorts comparison confirmed higher morbidity, but not higher early mortality.CONCLUSION: Our data suggest that patients who receive neo-adjuvant therapy for lung cancer have worse early surgical outcomes. Although NSQIP does not provide stage information, this analysis shows important findings that should be considered when selecting patients for induction treatment. | Benedetto Mungo Cheryl K Zogg Francisco Schlottmann Arianna Barbetta Craig M Hooker Daniela Molena | 2016 | World Journal of Surgical Procedures2016，6，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员